Physician

Ahmad Fora, MD

According to 2025 Medicare claims, Ahmad Fora, MD (NPI: 1386875011) practices hematology/oncology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 98584-9998. Fora is affiliated with the AdvantagePoint Health Alliance - Northwest, LLC (ACO ID: A5025) and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Fora's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 767 traditional Medicare patients, billed 173,727 HCPCS/CPT codes, and received $2,998,782 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 818 prescription claims across 148 beneficiaries totaling $1,836,208 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 75 claims. Open Payments data shows 188 records totaling $4,468. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,065,993 and ending at $2,998,782. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $882,914 to $1,836,208. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $1,065,993 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $921,248 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $54,463 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $99,873 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $145,564 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $108,747 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $138,251 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $134,445 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $475,701 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,998,782 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201536298,745$1,065,993
201629449,207$921,248
2017330937$54,463
20184551,805$99,873
20197252,702$145,564
20205842,157$108,747
20215402,151$138,251
20225562,148$134,445
202378226,731$475,701
2024767173,727$2,998,782

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.5M2015 Drug cost: $882,914 (USD; Tot_Drug_Cst)2016 Drug cost: $725,191 (USD; Tot_Drug_Cst)2017 Drug cost: $294,080 (USD; Tot_Drug_Cst)2018 Drug cost: $854,935 (USD; Tot_Drug_Cst)2019 Drug cost: $2,475,692 (USD; Tot_Drug_Cst)2020 Drug cost: $1,840,294 (USD; Tot_Drug_Cst)2021 Drug cost: $2,115,842 (USD; Tot_Drug_Cst)2022 Drug cost: $2,428,860 (USD; Tot_Drug_Cst)2023 Drug cost: $1,682,974 (USD; Tot_Drug_Cst)2024 Drug cost: $1,836,208 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151551,269$882,914
2016148812$725,191
2017124503$294,080
20181771,227$854,935
20192351,897$2,475,692
20201771,501$1,840,294
20211751,578$2,115,842
20221871,605$2,428,860
2023196954$1,682,974
2024148818$1,836,208

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$26K$52K2015 Medicare payment: $2,684 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $301 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $11,032 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,834 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,180 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $34,319 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $52,236 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$2,684
2016N/R16$301
2017N/RN/RN/R
2018N/R77$11,032
2019N/R50$5,834
2020N/R31$3,180
2021N/R90$34,319
2022N/RN/RN/R
2023N/R75$52,236
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3571,204$97
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more328499$63
96372Injection of drug or substance under skin or into muscle138341$11
36415Insertion of needle into vein for collection of blood sample4811,579$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4101,450$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide20560$337,244
NubeqaDarolutamide25750$323,558
Abiraterone AcetateAbiraterone Acetate27810$194,747
ImbruvicaIbrutinib14406$100,209
VenclextaVenetoclax11309$48,900

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.188$4,468ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmad Fora, MD?

Tedicare shows public-source Medicare data for Ahmad Fora, MD (NPI 1386875011), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Fora, MD have ACO affiliation data?

Ahmad Fora, MD is shown with ACO affiliation data for AdvantagePoint Health Alliance - Northwest, LLC (MSSP, ACO ID A5025) and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Ahmad Fora, MD?

Ahmad Fora, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Ahmad Fora, MD have Open Payments data?

Ahmad Fora, MD has 188 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.